"Dose or Strength to be Studied" in ICH M13A [Regulatives / Guidelines]

posted by BEQool  – 2024-10-07 12:33 (214 d 23:49 ago) – Posting: # 24221
Views: 1,527

Hello,

I was wondering the exact same thing but I think that this red text applies just to high-risk products with less than proportional increases in AUC and/or Cmax with increasing dose over the range of strengths proposed (the latter explanation of yours).
Otherwise this would have been written at least in a seperate paragraph as this whole paragraph is talking about less than proportional increases in AUC and/or Cmax with increasing dose.

Regards
BEQool

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
103 visitors (0 registered, 103 guests [including 5 identified bots]).
Forum time: 12:23 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5